Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon
- PMID: 29973151
- PMCID: PMC6030765
- DOI: 10.1186/s12872-018-0873-6
Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon
Abstract
Background: Despite marked advances in our understanding of the pathophysiology of the coronary slow flow phenomenon (CSFP), the exact mechanism remains unclear. Previous studies have suggested that CSFP might be associated with generalized atherosclerosis, endothelial dysfunction, and low-grade chronic inflammation. High serum alkaline phosphatase (ALP) levels are associated with vascular calcification, atherosclerotic disease, and an increased risk of cardiovascular events. However, the relationship between ALP and CSFP is unclear.
Methods: We investigated 64 patients with angiographically proven CSFP and 50 with normal coronary flow. Serum ALP levels were measured in all studied individuals.
Results: Serum ALP levels in patients with CSFP were significantly higher than those in the control group (70.5 ± 17.1 vs. 61.9 ± 16.1 U/L, P = 0.007). A positive association was observed (r = 0.42, P = 0.032) between serum ALP levels and the mean thrombolysis in myocardial infarction frame count (mTFC). Regression analysis showed a high serum ALP level was the only independent predictor of the mTFC (β = 0.309, P < 0.001). Moreover, our study showed that a serum ALP level > 67.5 U/L was a predictor of CSFP (sensitivity = 83.3%, specificity = 84.1%).
Conclusions: Patients with CSFP show high serum ALP levels, which may be associated with the pathogenesis of CSFP. A high serum ALP level is a predictor of CSFP. Future studies are needed to clarify the role of ALP in patients with CSFP.
Keywords: Coronary angiography; Coronary slow flow phenomenon; Serum alkaline phosphatase; TIMI flame count.
Conflict of interest statement
Ethics approval and consent to participate
The study had already been approved by Ethics Committee of the First Hospital of China Medical University and all subjects provided their informed, written consent before participation.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
Relationship between serum mature brain-derived neurotrophic factor level and coronary slow flow phenomenon: a cross-sectional study.Sci Rep. 2025 Apr 29;15(1):14990. doi: 10.1038/s41598-025-98213-7. Sci Rep. 2025. PMID: 40301477 Free PMC article.
-
Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no obstructive coronary arteries.BMC Cardiovasc Disord. 2024 Oct 26;24(1):595. doi: 10.1186/s12872-024-04281-4. BMC Cardiovasc Disord. 2024. PMID: 39462315 Free PMC article.
-
Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.BMC Cardiovasc Disord. 2024 Jul 13;24(1):358. doi: 10.1186/s12872-024-04040-5. BMC Cardiovasc Disord. 2024. PMID: 39003493 Free PMC article.
-
Diagnostic Indicators of ECG for Coronary Slow Flow Phenomenon; a Systematic Review and Meta-Analysis.Arch Acad Emerg Med. 2024 Mar 3;12(1):e34. doi: 10.22037/aaem.v12i1.2202. eCollection 2024. Arch Acad Emerg Med. 2024. PMID: 38721444 Free PMC article. Review.
-
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management.Angiology. 2021 Oct;72(9):808-818. doi: 10.1177/00033197211004390. Epub 2021 Mar 29. Angiology. 2021. PMID: 33779300 Review.
Cited by
-
Alkaline Phosphatase Activity Is a Key Determinant of Vascular Responsiveness to Norepinephrine.Hypertension. 2020 Oct;76(4):1308-1318. doi: 10.1161/HYPERTENSIONAHA.120.15822. Epub 2020 Aug 24. Hypertension. 2020. PMID: 32829665 Free PMC article.
-
Long-Term Prognosis in Patients with Coronary Slow Flow.J Tehran Heart Cent. 2022 Oct;17(4):202-206. doi: 10.18502/jthc.v17i4.11608. J Tehran Heart Cent. 2022. PMID: 37143748 Free PMC article.
-
Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs.Int J Mol Sci. 2023 Apr 12;24(8):7142. doi: 10.3390/ijms24087142. Int J Mol Sci. 2023. PMID: 37108311 Free PMC article.
-
Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study.Front Endocrinol (Lausanne). 2023 Jun 5;14:1147458. doi: 10.3389/fendo.2023.1147458. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37342261 Free PMC article.
-
Emerging Predictors by Non-HDL-C/HDL-C Ratio and Novel Biomarkers for Coronary Slow Flow Phenomenon.Acta Cardiol Sin. 2024 Jul;40(4):367-372. doi: 10.6515/ACS.202407_40(4).20240624A. Acta Cardiol Sin. 2024. PMID: 39045366 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources